Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 31, Issue 1, Pages 111-119
Publisher
Oxford University Press (OUP)
Online
2015-07-09
DOI
10.1093/ndt/gfv249
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exonic Mutations ofTSC2/TSC1Are Common but Not Seen in All Sporadic Pulmonary Lymphangioleiomyomatosis
- (2013) Kameswara Rao Badri et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
- (2013) John J Bissler et al. LANCET
- Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma
- (2013) D. A. Krueger et al. NEUROLOGY
- Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference
- (2013) Darcy A. Krueger et al. PEDIATRIC NEUROLOGY
- Population Pharmacokinetics and Pharmacogenetics of Everolimus in Renal Transplant Patients
- (2012) Dirk Jan A.R. Moes et al. CLINICAL PHARMACOKINETICS
- Lymphangioleiomyomatosis — a wolf in sheep’s clothing
- (2012) Elizabeth P. Henske et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
- (2012) David Neal Franz et al. LANCET
- Tuberous Sclerosis Complex–Associated Angiomyolipomas: Focus on mTOR Inhibition
- (2011) Klemens Budde et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Everolimus: an mTOR inhibitor for the treatment of tuberous sclerosis
- (2011) David Neal Franz Expert Review of Anticancer Therapy
- Inhibition of MTOR Disrupts Autophagic Flux in Podocytes
- (2011) D. P. Cina et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Tuberous Sclerosis Complex: Neurological, Renal and Pulmonary Manifestations
- (2011) D. N. Franz et al. NEUROPEDIATRICS
- Angiomyolipoma Have Common Mutations in TSC2 but No Other Common Genetic Events
- (2011) Wei Qin et al. PLoS One
- Tuberous sclerosis complex: tumors and tumorigenesis
- (2010) Julita Borkowska et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Relation Between Kidney Function, Proteinuria, and Adverse Outcomes
- (2010) Brenda R. Hemmelgarn JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis
- (2010) Darcy A. Krueger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tuberous Sclerosis Complex: Diagnostic Challenges, Presenting Symptoms, and Commonly Missed Signs
- (2010) B. A. Staley et al. PEDIATRICS
- Angiomyolipomata: challenges, solutions, and future prospects based on over 100 cases treated
- (2009) Prasanna Sooriakumaran et al. BJU INTERNATIONAL
- A case of tuberous sclerosis complex that progressed to end-stage renal disease
- (2009) Mohammad Sarraf et al. Nature Reviews Nephrology
- The pathogenesis and imaging of the tuberous sclerosis complex
- (2008) Henry J. Baskin PEDIATRIC RADIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now